✦ LIBER ✦

Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non–HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes

✍ Scribed by Ruth S. Weinstock; Ronald B. Goldberg; John R. Guyton; Theodore Mazzone; Adam Polis; Joanne E. Tomassini; Jianxin Lin; Arvind Shah; Andrew M. Tershakovec

Book ID: 119287116
Publisher: Elsevier
Year: 2008
Tongue: English
Weight: 295 KB
Volume: 2
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2008.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PO23-777 EFFECT OF EZETIMIBE/SIMVASTATIN

PO23-777 EFFECT OF EZETIMIBE/SIMVASTATIN VERSUS ATORVASTATIN ON ATTAINING RECOMMENDED LEVELS OF LDL-C, APOLIOPROTEIN B, NON-HDL-C AND HS-CRP IN TYPE 2 DIABETES

✍ Weinstock, R.S.; Goldberg, R.B.; Guyton, J.R.; Mazzone, T.; Polis, A.; Tomassini 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Abstract: 582 ATTAINMENT OF SINGLE/DUAL

Abstract: 582 ATTAINMENT OF SINGLE/DUAL TREATMENT LEVELS FOR LDL-C AND NON-HDL-C, APOB, OR HS-CRP IN PATIENTS WITH METABOLIC SYNDROME (MS): EZETIMIBE(E)/SIMVASTATIN(S) VS ATORVASTATIN(A)

✍ Ballantyne, C; Grundy, S; Hsueh, W; Parving, H; Robinson, J; Rosen, J; Lin, J; L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 233 KB

PO23-786 ASSOCIATION BETWEEN BASELINE LD

PO23-786 ASSOCIATION BETWEEN BASELINE LDL-C, TRIGLYCERIDES, AND HDL-C LEVELS AND THE LIPID-ALTERING AND HS-CRP EFFICACIES OF EZETIMIBE/SIMVASTATIN VERSUS ATORVASTATIN IN TYPE 2 DIABETES PATIENTS: THE VYTAL STUDY

✍ Goldberg, R.B.; Guyton, J.R.; Mazzone, T.; Weinstock, R.S.; Polis, A.; Tomassini 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Ezetimibe/Simvastatin + Extended Release

Ezetimibe/Simvastatin + Extended Release Niacin Therapy Improves Attainment of Recommended Levels of LDL-C, Non-HDL-C, and ApoB in Hyperlipidemic Patients

✍ Sergio Fazio; John Guyton; Jianxin Lin; Joanne Tomassini; Arvind Shah; Andrew Te 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 207 KB

82 COMBINATION EZETIMIBE/SIMVASTATIN + E

82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS

✍ Fazio, S.; Guyton, J.R.; Lin, J.; Tomassini, J.E.; Shah, A.; Tershakovec, A.M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

M.464 Effect of rosuvastatin and atorvas

M.464 Effect of rosuvastatin and atorvastatin on LDL-C and CRP levels in patients with type-2 diabetes: Results of the andromeda study

✍ Betteridge, D.; Gibson, M. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 275 KB